Adverse Drug Reaction Among Patients Who Received Vincristine and Actinomycin D fro Treatment of Wilms Tumour at Bugando Medical Centre. (Record no. 20947)

MARC details
000 -LEADER
fixed length control field 02275nam a22001817a 4500
001 - CONTROL NUMBER
control field CUHAS/BP/3000268/T/15
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210809b |||||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Panga, Neema
Dates associated with a name CUHAS/BP/3000268/T/15
9 (RLIN) 20953
Relator term Undergraduate Ethical Clearance Certificate No. 932/2019
245 ## - TITLE STATEMENT
Title Adverse Drug Reaction Among Patients Who Received Vincristine and Actinomycin D fro Treatment of Wilms Tumour at Bugando Medical Centre.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Mwanza, Tanzania
Name of publisher, distributor, etc. Catholic University of Health and Allied Sciences [CUHAS - Bugando]
-- Phone: +255 28 298 3384 :
-- Fax: +255 28 298 3386 :
-- Email: vc@bugando.ac.tz :
-- Website: www.bugando.ac.tz :
Date of publication, distribution, etc. ©30.08.2019
300 ## - PHYSICAL DESCRIPTION
Extent x; 18 Pages
Extent Includes References and Appendices
520 ## - SUMMARY, ETC.
Summary, etc. Abstract:<br/><br/>Background: Wilms tumour is an embryonal tumour of the kidney and mostly it affects children and is the second most common childhood malignancy affecting children under 5 years. Actinomycin D and vincristine have been observed to be the most effective drugs for management of Wilms tumour.<br/><br/>Methodology: Retrospective cross-sectional hospital-based study conducted at oncology department in Bugando medical centre, Tanzania. Study included 80 Wilms tumours patients’ files from January 2010 to December 2018 selected by consecutive sampling. Data was filled in excel and analysed using STATA version 13. <br/><br/>Results and Discussion: The age group affected mostly was 1-5 years. The most chemotherapy prescribed was combination of Actinomycin D and Vincristine (58.75%), vincristine (40%) and Actinomycin D (1.25%). Adverse reactions observed were anemia (41.25%), vomiting (7.5%), neutropenia and eye discharge. About 43.73% showed no documentation on the adverse drugs reactions. <br/><br/>Conclusion and Recommendations: Adverse drug reactions associated with the use of vincristine were anemia, vomiting and neutropenia. Combined therapy was associated with anemia, eye discharge and vomiting. Actinomycin D was associated with anemia. There must be a documentation of the adverse drug reactions by the health practitioners to make a better choice during a therapeutic plan. <br/>
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Pharmacy
9 (RLIN) 26693
General subdivision Pharmacology
9 (RLIN) 30211
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 20952
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type UNDERGRADUATE DISSERTATIONS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   08/09/2021   UD0903 08/09/2021 08/09/2021 UNDERGRADUATE DISSERTATIONS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024